These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9153164)

  • 21. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection.
    Webber KM; Bowen R; Casadesus G; Perry G; Atwood CS; Smith MA
    Acta Neurobiol Exp (Wars); 2004; 64(1):113-8. PubMed ID: 15190686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.
    Inestrosa NC; Marzolo MP; Bonnefont AB
    Mol Neurobiol; 1998; 17(1-3):73-86. PubMed ID: 9887447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of estrogen replacement therapy in Alzheimer's disease.
    Panidis DK; Matalliotakis IM; Rousso DH; Kourtis AI; Koumantakis EE
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):86-91. PubMed ID: 11267726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen and cognitive aging in women.
    Sherwin BB
    Trends Pharmacol Sci; 2002 Nov; 23(11):527-34. PubMed ID: 12413808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function?
    Bieber EJ; Cohen DP
    Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estrogens and Alzheimer disease].
    Stähelin HB
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can variability in the hormonal status of elderly women assist in the decision to administer estrogens?
    Kuchel GA; Tannenbaum C; Greenspan SL; Resnick NM
    J Womens Health Gend Based Med; 2001 Mar; 10(2):109-16. PubMed ID: 11268296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
    Casadesus G; Garrett MR; Webber KM; Hartzler AW; Atwood CS; Perry G; Bowen RL; Smith MA
    Drugs R D; 2006; 7(3):187-93. PubMed ID: 16752944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oestrogens and dementia.
    Henderson VW
    Novartis Found Symp; 2000; 230():254-65; discussion 265-73. PubMed ID: 10965513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers.
    Miller KJ
    Curr Psychiatry Rep; 2003 Dec; 5(6):439-44. PubMed ID: 14609498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dementia: risk and protective factors with special consideration of gender and hormone replacement therapy].
    Stoppe G
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):217-22. PubMed ID: 10802897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age.
    Henderson VW; Benke KS; Green RC; Cupples LA; Farrer LA;
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):103-5. PubMed ID: 15608005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial.
    Henderson VW; Paganini-Hill A; Miller BL; Elble RJ; Reyes PF; Shoupe D; McCleary CA; Klein RA; Hake AM; Farlow MR
    Neurology; 2000 Jan; 54(2):295-301. PubMed ID: 10668686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen replacement therapy and risk of Alzheimer disease.
    Paganini-Hill A; Henderson VW
    Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease: an estrogen link?
    Beckmann CR
    Curr Opin Obstet Gynecol; 1997 Oct; 9(5):295-9. PubMed ID: 9360809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oestrogens and Alzheimer's disease.
    Birkhäuser MH; Strnad J; Kämpf C; Bahro M
    Int J Geriatr Psychiatry; 2000 Jul; 15(7):600-9. PubMed ID: 10918340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen therapy and Alzheimer's dementia.
    Craig MC; Murphy DG
    Ann N Y Acad Sci; 2010 Sep; 1205():245-53. PubMed ID: 20840280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.